Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2010
10/13/2010CN101861319A Benzazepinone compound
10/13/2010CN101861309A SALARIN and TULEARIN, compositions and uses thereof
10/13/2010CN101861302A Pyrrolidine aryl-ether as NK3 receptor antagonists
10/13/2010CN101857597A Diethylene triamine pentaacetic acid or ethylene diamine tetraacetic acid or amine triacetic acid modified porphyrin, preparation method and application thereof
10/13/2010CN101857596A Synthetic method of mono-N-tert-butoxycarbonyl-2,6-diazaspiro[3,3]heptane oxalate
10/13/2010CN101857595A Quinnazolidone derivative, preparation method thereof and purpose of serving as anticarcinogen
10/12/2010US7812177 Potassium channel opener having benzofuroindole skeleton
10/12/2010US7812158 Coupling agents for peptide synthesis
10/12/2010US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease
10/12/2010US7812024 such as (4R,11aR)-4-methyl-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one, used for the treatment of obesity, diabetes, atherosclerosis, dyslipidemia, anxiety, depression, psychosis, schizophrenia, sleep, sexual, obsessive compulsive and gastrointestinal disorders
10/12/2010US7812021 {(3RS,4SR)-3-(3,4-dichloro-phenyl)-4-[(RS)-1-(4-trifluoromethyl-phenoxy)-ethyl]-pyrrolidin-1-yl}-(4-methanesulfonyl-piperazin-1-yl)-methanone, for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2441110C Pharmaceutical compositions for treating arteriosclerosis
10/12/2010CA2329751C Substituted porphyrins
10/07/2010WO2010114996A2 Method for preparing cha-type molecular sieves using novel structure directing agents
10/07/2010WO2010114958A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
10/07/2010WO2010114894A1 Substituted heterocyclic compounds
10/07/2010WO2010114267A2 Organic electronic device, compounds for same, and terminal
10/07/2010WO2010114038A1 Novel azomethine compound and thermal transfer sheet using the same azomethine compound pigment
10/07/2010WO2010113958A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases
10/07/2010WO2010113755A1 Material for phosphorescent light-emitting element and organic electroluminescent element using same
10/07/2010WO2010113726A1 Material for use in phosphorescent device and organic electroluminescent device using same
10/07/2010WO2010112486A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112485A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112484A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112452A1 Oligocondensed perylene bisimides
10/07/2010WO2010112437A1 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
10/07/2010WO2010111905A1 Pharmaceutical composition for treatment of 2 type dabetes
10/07/2010WO2010091067A3 Derivatives of [1, 3] oxazin- 2-one useful for the treatment of metabolic diseases such as lipid disorders
10/07/2010WO2010039825A3 Imidazo [1, 2-a] pyridine compounds as receptor tyrosine kinase inhibitors
10/07/2010US20100256355 Oxazolidinone derivative having 7-membered hetero ring
10/07/2010US20100256354 Method and apparatus for separating isomers of chiral substance
10/07/2010US20100256171 Selective serine/threonine kinase inhibitors
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256168 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
10/07/2010US20100256167 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
10/07/2010US20100256135 Pyrimido-benzimidzole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
10/07/2010US20100256115 Inhibitors of iap
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp
10/07/2010US20100256082 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
10/07/2010US20100255117 Methods and compositions for the treatment of cancer
10/07/2010US20100254910 Methods and compositions for diagnostic and therapeutic targeting of cox-2
10/07/2010US20100252112 Semiconducting Compounds and Devices Incorporating Same
10/07/2010CA2757476A1 Method for preparing cha-type molecular sieves using novel structure directing agents
10/07/2010CA2757396A1 Medical composition for treatment or prophylaxis of eye diseases
10/07/2010CA2757231A1 1-heterocyclyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
10/07/2010CA2756871A1 Substituted heterocyclic compounds
10/06/2010EP2236511A2 Ligands of alpha-adrenoceptors and of dopamine, histamine, imidazoline and serotonin receptors and the use thereof
10/06/2010EP2235020A1 Pyrazolo [1,5-a] pyrimidine compounds
10/06/2010EP2235010A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
10/06/2010EP2235004A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
10/06/2010EP2234973A1 Anthelmintic agents and their use
10/06/2010EP1987038B1 Hcv ns5b inhibitors
10/06/2010EP1723144B1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/06/2010EP1515965B1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
10/06/2010EP1272492B1 Method for producing triethylene diamine, using ethylene diamine
10/06/2010CN1769286B Compound and pharmaceutical composition for treating nasal oversecreation and chronic obstructive pulmonary disease
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN101855222A Imidazol (1,2-A)pyridines and related compounds with activity at cannabinoid CB2 receptors
10/06/2010CN101851241A Anti-tumor compound and preparation method and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101337964B Swine blood bovine and method for preparing same
10/06/2010CN101062928B Process for preparing 2-pyrrolidinyl-1h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
10/05/2010US7807844 Reaction product of N-methylpyrrole, N-methylimidazole, 4-aminobutyric acid and B-alanine that can be folded into a U-shaped conformation at the gamma -aminobutyrate unit in a minor groove of a double helix region; conjugates with fluorescein isothiocyanate; antiproliferative agents; restenosis
10/05/2010US7807836 Dimerizing a naphthalene-1,8-dicarboximide, reoxidation of the resulting perylene-3,4:9,10-tetracarboxylic diimide, hydrolyzing the diimide to the tetraalkali metal salt of perylene-3,4:9,10-tetracarboxylic acid, convert it into perylene-3,4:9,10-tetracarboxylic dianhydride
10/05/2010US7807825 superoxide dismutase mimetics such as manganese(III) 5,10,15,20-tetrakis[N,N'-diethylimidazolium-2-yl]porphyrin, used for the treatment for oxidative stress injuries, including asthma, neurodegenerative disease, cancer, diabetes, cardiovascular disorders, sickle cell anemia and radiation injury
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807687 Reaction of a 2,4-disubstituted quinolinone with an aldehyde in the presence of a base to prepare a benzylidene hydroquinolinone, reaction of product with benzamidinium hydrochloride under basic conditions to prepare a 1,4,5,6-tetrahydropyrido[3,2-h]quinazoline, oxidation; performance efficiency; OLED
10/05/2010US7807683 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010CA2369595C Conjugate having a cleavable linkage for use in a liposome
10/05/2010CA2352679C Process for the preparation of 3-aryl-benzofuran-2-ones
09/2010
09/30/2010WO2010111718A2 Antiviral compounds and methods of use thereof
09/30/2010WO2010111406A2 Compounds and therapeutic uses thereof
09/30/2010WO2010111381A2 Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one
09/30/2010WO2010110400A1 Heterocyclic compound
09/30/2010WO2010109287A1 Fused pyrimidine-dione derivatives as trpa1 modulators
09/30/2010WO2010108873A1 Diketopyrrolopyrrole polymers for use in organic semiconductor devices
09/30/2010WO2010108268A1 Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010WO2010077852A3 Method of inducing cleavage of amyloid precursor protein to form a novel fragment
09/30/2010WO2010068483A3 Mlk inhibitors and methods of use
09/30/2010WO2010046273A3 Pyrimidinyl pyridone inhibitors of jnk
09/30/2010US20100249408 Use of novel compound having affinity for amyloid, and process for production of the same
09/30/2010US20100249407 Novel Compound Having Affinity to Amyloid
09/30/2010US20100249157 Lpa receptor antagonist
09/30/2010US20100249153 Substituted indolo-piperidine compounds
09/30/2010US20100249152 New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof
09/30/2010US20100249151 Imidazo 1, 2-a pyrimidine derivatives for the treatment of diseases such as diabetes
09/30/2010US20100249142 IMIDAZOL[1,2-alpha]QUINOXALINES AND DERIVATIVES FOR THE TREATMENT OF CANCERS
09/30/2010US20100249140 Solid state forms of sitagliptin salts
09/30/2010US20100249132 Imidazole derivatives
09/30/2010US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
09/30/2010US20100249110 Substituted pyrazolo-pyrimidine compounds
09/30/2010US20100249109 Substituted tetrahydropyrazolo-pyrido-azepine compounds
09/30/2010US20100249106 Methods of Making and Using Therapeutically Active Thiophenepyrimidinone Compounds
09/30/2010US20100249105 Indole and indoline derivatives and methods of use thereof
09/30/2010US20100249099 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
09/30/2010US20100249095 Substituted Spiro-amide Compounds
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 573